FSCN1 and ovarian cancer: In vitro and in vivo data showed that the loss of FSCN1 significantly inhibited trans-mesothelial migration of the ovarian cancer cell line ES-2 and reduced the interaction between ovarian cancer cells and mesothelial cells in the mouse peritoneal cavity [148].